News

In 2026, Lygature marks 20 years of pioneering partnerships for patient impact. As part of our anniversary year, we are sharing a series of stories highlighting the partnerships, initiatives, and expertise that have shaped our organization and contributed to health innovation over the past two decades.

In 2026, Lygature celebrates 20 years of bringing people, expertise and organizations together to advance health innovation. Under the theme “20 years of pioneering partnerships for patient impact”, we reflect on our journey and look ahead with collaborative ambition that continues to drive us forward.

Lygature's Q1 2026 Newsletter is now available, featuring highlights from across our partnerships and projects.

Lygature Managing Director Jorg Janssen recently joined the Leaders in Life Sciences podcast, hosted by Henk Jan Out, to discuss the evolving role of collaboration in advancing healthcare innovation.

The ImmuneHealth-4-All public–private partnership programme has been awarded €6.6 million in funding through the Health~Holland PPS programme to promote public private partnerships.

With a very heavy heart we announce the passing of our dear colleague, Herman Verheij. He died last Thursday, January 22, in a car accident. Herman's expertise, warmth, humour, generosity of spirit and joyful presence will be dearly missed by all of us at Lygature. As we try to come to terms with this sudden and devastating loss, our thoughts are foremost with his loved ones.

De best passende zorg met medicijnen ontstaat wanneer de kennis en ervaring van patiënten en medicijnbedrijven elkaar versterken. Toch worden patiënten nog niet standaard betrokken bij de ontwikkeling en toepassing van medicijnen.

Lygature is proud to announce the launch of END2AMR (European Novel Drug Research to Address Microbial Infections and Drug Resistance) – a new public-private research initiative designed to tackle some of the most difficult-to-treat bacterial infections.

The Pediatric Praziquantel Consortium — coordinated by Lygature — was recently nominated for the 2025 Prix Galien Bridges Award in the category Best Public Sector Innovation. 

Antimicrobial resistance (AMR) remains one of the greatest threats to global health. As the World Health Organization (WHO) reminds us in its 2025 campaign for World AMR Awareness Week, this is a challenge for everyone, everywhere.

Last week in Utrecht, the Trials@Home consortium gathered for its Annual Consortium Meeting and its Closing Event — a moment to celebrate achievements, share lessons learned, and look ahead to the future of decentralised clinical trials (DCTs).

Earlier this week, Olenka van Ardenne, Senior Partnership Leader at Lygature, was appointed as a member of the Supervisory Board of CumuluZ – Dutch initiative dedicated to improving data availability in healthcare.

We are pleased to announce several updates to our Board of Directors (BoD), reinforcing the Lygature Foundation’s continued commitment to strong governance and strategic guidance in advancing public-private collaboration in life sciences and health.

Last week, Lygature formally concluded its involvement in the initiation phase of the National Growth Fund program Ombion Centre for Animal-free Biomedical Translation, following a successful period of collaboration that helped establish a solid basis for the program’s long-term success.

The latest edition of our quarterly newsletter is out, featuring key milestones and updates from Q2 2025.